<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00734409</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00002117</org_study_id>
    <secondary_id>DUHS parent 3930938</secondary_id>
    <nct_id>NCT00734409</nct_id>
  </id_info>
  <brief_title>Combining Objective and Subjective Sedation Assessment Tools</brief_title>
  <acronym>COST_2</acronym>
  <official_title>Combining Objective and Subjective Sedation Assessment Tools - Second Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the use of a device called the BIS monitor in
      addition to the Richmond Agitation Sedation Scale will give better assessment of a subject's
      level of sedation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in the intensive care unit (ICU) who require a ventilator to help them breathe also
      require sedation in order to keep them comfortable and prevent injury. The national
      guidelines for sedation management include a daily interruption of sedation performed once
      each morning. To determine the amount of sedation needed, the current standard practice is to
      use a system called the Richmond Agitation-Sedation Scale (RASS). The patient is stimulated
      by calling their name or by tapping their shoulder until the patient's responses indicate
      that a satisfactory level of sedation has been achieved.

      The purpose of this study is to determine if the use of a device called the BIS monitor in
      addition to the RASS will give better assessment of a subject's level of sedation. The BIS
      monitor is a sensor strip taped to the forehead and attached to a device that reads
      electrical activity from the brain. It is approved by the U.S. Food and Drug Administration
      (FDA) for monitoring patients under sedation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Sedative Use</measure>
    <time_frame>Intensive Care Unit (ICU) stay through discharge</time_frame>
    <description>The mean amount of propofol used on each patient while the patient was in the ICU and receiving mechanical ventilation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unplanned Self-device Removal Events</measure>
    <time_frame>ICU stay through discharge</time_frame>
    <description>The number of unplanned self-device removal events that took place during the study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Days on Mechanical Ventilation</measure>
    <time_frame>ICU stay- through discharge</time_frame>
    <description>The mean number of days that the patients were on mechanical ventilation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>RASS plus (BIS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with Bispectral Index (BIS) Monitor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RASS only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bispectral Index (BIS) Monitor</intervention_name>
    <description>BIS monitoring in addition to RASS assessments</description>
    <arm_group_label>RASS plus (BIS)</arm_group_label>
    <other_name>Richmond agitation sedation scale</other_name>
    <other_name>neurofunction monitor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient in the ICU

          -  continuous IV sedation with propofol midazolam or dexmedetomidine

          -  age &gt; 18

          -  expected to require mechanical ventilation for &gt;=48 hours

        Exclusion Criteria:

          -  prisoners

          -  no available space on forehead

          -  continuous electroencephalography(EEG) monitoring

          -  bifrontal brain injury

          -  barbiturate coma therapy

          -  known hypersensitivity to study medications

          -  high risk for ethanol (ETOH) withdrawal

          -  resuscitation from cardiac arrest without recovery of mental status

          -  moribund clinical state (death expected within 48 hours)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DaiWai M Olson, PhD RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2008</study_first_submitted>
  <study_first_submitted_qc>August 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2008</study_first_posted>
  <results_first_submitted>August 10, 2012</results_first_submitted>
  <results_first_submitted_qc>August 10, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2012</results_first_posted>
  <last_update_submitted>March 21, 2013</last_update_submitted>
  <last_update_submitted_qc>March 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Human</keyword>
  <keyword>conscious sedation</keyword>
  <keyword>bispectral index</keyword>
  <keyword>monitoring</keyword>
  <keyword>critical care</keyword>
  <keyword>propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were in the Medical ICU or Neuro ICU at Duke University Hospital or the mixed ICU at Durham Regional. If patients met all inclusion criteria and no exclusion criteria, the attending was asked if patient's legally authorized representative (LAR) could be approached for consent. Enrollment started May of 2008 and closed April of 2011.</recruitment_details>
      <pre_assignment_details>Patients were only excluded from the trial after consent and prior to randomization if they no longer met inclusion criteria, for instance the medical team decided to remove sedatives.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RASS Plus BIS</title>
          <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
        </group>
        <group group_id="P2">
          <title>RASS Only</title>
          <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="155"/>
                <participants group_id="P2" count="145"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="155"/>
                <participants group_id="P2" count="145"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>RASS Plus BIS</title>
          <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
        </group>
        <group group_id="B2">
          <title>RASS Only</title>
          <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="155"/>
            <count group_id="B2" value="145"/>
            <count group_id="B3" value="300"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="201"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.95" spread="18.15"/>
                    <measurement group_id="B2" value="57.7" spread="15.30"/>
                    <measurement group_id="B3" value="55.78" spread="16.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="155"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Sedative Use</title>
        <description>The mean amount of propofol used on each patient while the patient was in the ICU and receiving mechanical ventilation.</description>
        <time_frame>Intensive Care Unit (ICU) stay through discharge</time_frame>
        <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>RASS Plus BIS</title>
            <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
          </group>
          <group group_id="O2">
            <title>RASS Only</title>
            <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Sedative Use</title>
          <description>The mean amount of propofol used on each patient while the patient was in the ICU and receiving mechanical ventilation.</description>
          <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
          <units>ml/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="155"/>
                <count group_id="O2" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.35" spread="11.79"/>
                    <measurement group_id="O2" value="15.54" spread="11.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unplanned Self-device Removal Events</title>
        <description>The number of unplanned self-device removal events that took place during the study period.</description>
        <time_frame>ICU stay through discharge</time_frame>
        <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>RASS Plus BIS</title>
            <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
          </group>
          <group group_id="O2">
            <title>RASS Only</title>
            <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Self-device Removal Events</title>
          <description>The number of unplanned self-device removal events that took place during the study period.</description>
          <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
          <units>Event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="155"/>
                <count group_id="O2" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Days on Mechanical Ventilation</title>
        <description>The mean number of days that the patients were on mechanical ventilation.</description>
        <time_frame>ICU stay- through discharge</time_frame>
        <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>RASS Plus BIS</title>
            <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
          </group>
          <group group_id="O2">
            <title>RASS Only</title>
            <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Days on Mechanical Ventilation</title>
          <description>The mean number of days that the patients were on mechanical ventilation.</description>
          <population>All patients who met eligibility requirements, consented for the trial, and were randomized were included in the analysis.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="155"/>
                <count group_id="O2" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.43" spread="8.32"/>
                    <measurement group_id="O2" value="6.85" spread="12.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>RASS Plus BIS</title>
          <description>Participants in this arm will receive sedation assessment with the RASS scale augmented with BIS monitoring.</description>
        </group>
        <group group_id="E2">
          <title>RASS Only</title>
          <description>Participants will receive sedation assessment only using the RASS scale which is the standard of care at our institution</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="145"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.3</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="145"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Unplanned Self-Device Removal Event</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="145"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>DaiWai M Olson, PhD RN</name_or_title>
      <organization>Duke University Health System</organization>
      <phone>(919) 668-3751</phone>
      <email>Olson006@mc.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

